Mutations in the tumor suppressor gene adenomatous polyposis coli (APC) occur in ~80%–90% of CRC cases.14–19 APC is a key regulator of the Wnt/β-catenin signaling pathway, and loss of APC function is a critical driver of colorectal tumorigenesis. This evidence concerns the gene APC and colorectal carcinoma.